Nothing Special   »   [go: up one dir, main page]

SE9802213D0 - A method for the removal/purification of serum albumins and means for use in the method - Google Patents

A method for the removal/purification of serum albumins and means for use in the method

Info

Publication number
SE9802213D0
SE9802213D0 SE9802213A SE9802213A SE9802213D0 SE 9802213 D0 SE9802213 D0 SE 9802213D0 SE 9802213 A SE9802213 A SE 9802213A SE 9802213 A SE9802213 A SE 9802213A SE 9802213 D0 SE9802213 D0 SE 9802213D0
Authority
SE
Sweden
Prior art keywords
binding
ligand
albumin
serum albumin
derived
Prior art date
Application number
SE9802213A
Other languages
English (en)
Inventor
Hans Johansson
Original Assignee
Amersham Pharm Biotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Pharm Biotech Ab filed Critical Amersham Pharm Biotech Ab
Priority to SE9802213A priority Critical patent/SE9802213D0/sv
Publication of SE9802213D0 publication Critical patent/SE9802213D0/sv
Priority to AU48094/99A priority patent/AU4809499A/en
Priority to EP99931651A priority patent/EP1086133A1/en
Priority to JP2000554768A priority patent/JP2002518000A/ja
Priority to PCT/SE1999/000879 priority patent/WO1999065943A1/en
Priority to US09/719,511 priority patent/US6613884B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
SE9802213A 1998-06-18 1998-06-18 A method for the removal/purification of serum albumins and means for use in the method SE9802213D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9802213A SE9802213D0 (sv) 1998-06-18 1998-06-18 A method for the removal/purification of serum albumins and means for use in the method
AU48094/99A AU4809499A (en) 1998-06-18 1999-05-25 A method for the removal/purification of serum albumins and means for use in themethod
EP99931651A EP1086133A1 (en) 1998-06-18 1999-05-25 A method for the removal/purification of serum albumins and means for use in the method
JP2000554768A JP2002518000A (ja) 1998-06-18 1999-05-25 血清アルブミンの除去／精製のための方法およびその方法に使用する手段
PCT/SE1999/000879 WO1999065943A1 (en) 1998-06-18 1999-05-25 A method for the removal/purification of serum albumins and means for use in the method
US09/719,511 US6613884B1 (en) 1998-06-18 1999-05-25 Method for the removal/purification of serum albumins and means for use in the method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802213A SE9802213D0 (sv) 1998-06-18 1998-06-18 A method for the removal/purification of serum albumins and means for use in the method

Publications (1)

Publication Number Publication Date
SE9802213D0 true SE9802213D0 (sv) 1998-06-18

Family

ID=20411791

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9802213A SE9802213D0 (sv) 1998-06-18 1998-06-18 A method for the removal/purification of serum albumins and means for use in the method

Country Status (6)

Country Link
US (1) US6613884B1 (sv)
EP (1) EP1086133A1 (sv)
JP (1) JP2002518000A (sv)
AU (1) AU4809499A (sv)
SE (1) SE9802213D0 (sv)
WO (1) WO1999065943A1 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050037331A1 (en) * 2003-08-13 2005-02-17 William Galbraith Apparatuses and methods for reducing albumin in samples
US9296816B2 (en) 2005-04-15 2016-03-29 Macrogenics, Inc. Covalent diabodies and uses thereof
US11254748B2 (en) 2005-04-15 2022-02-22 Macrogenics, Inc. Covalent diabodies and uses thereof
US9284375B2 (en) 2005-04-15 2016-03-15 Macrogenics, Inc. Covalent diabodies and uses thereof
JP6023715B2 (ja) * 2010-10-11 2016-11-09 アッヴィ・バハマズ・リミテッド タンパク質の精製方法
RU2020115527A (ru) 2013-03-14 2020-07-07 Макродженикс, Инк. Биспецифичные молекулы, иммунореактивные с иммунными эффекторными клетками, экспрессирующими активирующий рецептор
US11384149B2 (en) 2013-08-09 2022-07-12 Macrogenics, Inc. Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof
UA116479C2 (uk) 2013-08-09 2018-03-26 Макродженікс, Інк. БІСПЕЦИФІЧНЕ МОНОВАЛЕНТНЕ Fc-ДІАТІЛО, ЯКЕ ОДНОЧАСНО ЗВ'ЯЗУЄ CD32B I CD79b, ТА ЙОГО ЗАСТОСУВАННЯ
EP2840091A1 (en) 2013-08-23 2015-02-25 MacroGenics, Inc. Bi-specific diabodies that are capable of binding gpA33 and CD3 and uses thereof
EP2839842A1 (en) 2013-08-23 2015-02-25 MacroGenics, Inc. Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof
JP6932639B2 (ja) 2014-09-29 2021-09-08 デューク ユニバーシティ Ｈｉｖ‐１エンベロープ標的化アームを備える二重特異性分子
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
MX2023007767A (es) 2020-12-28 2023-07-07 Davol Inc Materiales hemostaticos secos en polvo reactivos que comprenden una proteina y un agente de entrelazado a base de polietilenglicol modificado multifuncional.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633076A (en) * 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
AU669484B2 (en) * 1991-07-31 1996-06-13 Peri Development Applications (1985) Ltd Transgenic protein production
GB9414651D0 (en) * 1994-07-20 1994-09-07 Gene Pharming Europ Bv Separation of human serum albumin
US6268487B1 (en) * 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk

Also Published As

Publication number Publication date
EP1086133A1 (en) 2001-03-28
AU4809499A (en) 2000-01-05
WO1999065943A1 (en) 1999-12-23
US6613884B1 (en) 2003-09-02
JP2002518000A (ja) 2002-06-25

Similar Documents

Publication Publication Date Title
SE9802213D0 (sv) A method for the removal/purification of serum albumins and means for use in the method
CA2254108A1 (en) Improvements in or relating to specific binding assays
GB2345964A (en) Assay using porosity-reduction to inhibit migration
CA2275489A1 (en) Oil bodies and associated proteins as affinity matrices
ATE99060T1 (de) Testverfahren und reagenzsatz dazu.
FI104519B (sv) Analyssystem för glykerande blodproteiner
CA2162568A1 (en) Method and reagent for simultaneously assaying one or more ligands in a group of preselected ligands
DE3851967D1 (de) Verfahren zur Bestimmung von Antikörpern.
DE59409947D1 (de) Verringerung des Hook-Effekts in Immuntests mit teilchenförmigem Trägermaterial
WO2000061806A3 (en) GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS
HK115297A (en) Method of preparing biologically active reagents from succinimide-containing polymers analytical element and methods of use
AU1042901A (en) Lateral flow device utilising particulate carrier
DE3486350D1 (de) VERFAHREN ZUR ISOLIERUNG EINES PROTEINS AUS EINER DIESES PROTEIN ENTHALTENDEN MISCHUNG UNTER VERWENDUNG EINES KONFORMATIONSSPEZIFISCHEN ANTIKöRPERS.
DE59903121D1 (de) Kopieren und klonieren an oberflächen
ATE426158T1 (de) Mikrofluidisches extraktionsverfahren
DE59712595D1 (de) Homogene Nachweisverfahren zur Bestimmung von Subpopulationen eines Analyten
SE9300090D0 (sv) Affinitetsrening med komplexbunden ligand
CA2344193A1 (en) Cobalamin assay
DE69930843D1 (de) Verfahren zum bestimmen von autoantikörpern
ATE205222T1 (de) Abtrennung und charakterisierung des wachstumshormon-releasing-hormon-rezeptors
GB2214295B (en) "hapten determination method, use and components"
ES8701990A1 (es) Procedimiento para la determinacion de la capacidad de fijacion de la globulina fijadora de tiroxina
DE3863544D1 (de) Immunoassayverfahren zur blutgruppenbestimmung.
GILPIN Development of novel switchable protein surfaces(Final Report, 15 Mar. 1990- 31 Jul. 1993)
DE59108355D1 (de) Verfahren zur immunologischen Bestimmung von Liganden